State guide

Michigan Medicaid and GLP-1s

Michigan took a different route from most of the states on this site. Medicaid still pays for GLP-1s prescribed for obesity, but from January 1, 2026 the bar moved, and the state's numbered letter to providers spells out exactly where it moved to.

Every source on this page was read in September 2026. Each one is dated below with the date printed on the document itself.

All state guides

What changed, and what the document says

Point	Status	What the source says
Reduced, not removed	Conditions apply	The word the state uses is "reduced." Coverage survived; the criteria tightened. “Coverage of GLP-1 medications when prescribed solely to treat obesity, including requests for continuation, will be reduced.” Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025
The new bar	Not covered	Two conditions, both required: a morbid-obesity classification, and documented failure of everything else that was appropriate to try. “Patient must be classified as morbidly obese; and Coverage is contingent on documented failure of all other clinically appropriate weight-loss interventions (including a trial and failure of Preferred Drug List [PDL] preferred anti-obesity agents); and” Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025
The reason a prescription has to give	Conditions apply	Michigan frames the drug as an alternative to surgery. That framing is the criterion, not a comment. “Coverage must be considered only as a measure to avert the need for higher-cost bariatric surgery.” Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025
Everything else is untouched	Covered	Diabetes and the other approved uses carry on exactly as before. “Coverage of GLP-1 medications when requested for other existing indications other than to treat obesity will not be changing.” Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025
When it starts	Context	Dates of service from January 1, 2026. “Effective for Dates of Service On or After January 1, 2026:” Michigan Department of Health and Human Services, Program Policy Division — December 8, 2025

Which of these companies serve Michigan?

Of the 28 companies we grade, 4 publish a list of the states they are licensed in. We checked 23 more and found no such list on any page we read; 1 we have not checked either way.

3 of those lists name Michigan: Gala Health, Care Bare Rx and Vita Bella. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

If you're paying cash instead

None of the above changes what a telehealth seller charges you. These are the graded reviews worth reading first from here:

Mochi Health — Publishes starting prices that vary by dose and won't say which states it serves — two unknowns stacked on each other.
Ro — Its brand-name prices are the ones to compare against if a Michigan prior authorization comes back denied.
AgelessRx — Advertises a starting price tied to a four-month plan and never publishes the single-month figure.

Our grading method and how we verify a price explain what those letters mean.

Sources

Each document below was fetched and read in September 2026. The date shown is the one printed on the document, which is not always the date in its web address.

Update of Pharmacy Drug Coverage for Treatment of Obesity (L 25-73) — Michigan Department of Health and Human Services, Program Policy Division. the letter date printed at the top right: December 8, 2025. Read September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.